Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Cardiology

Clinical Pharmacology

Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction

ESC Heart Failure | Mar 13, 2021 Clinical Pharmacology

Fenofibrate delays the need for dialysis and reduces cardiovascular risk among patients with advanced CKD

Journal of Clinical Endocrinology and Metabolism | Mar 09, 2021 Clinical Pharmacology

Sodium bicarbonate administration during in-hospital pediatric cardiac arrest: A systematic review and meta-analysis

Resuscitation | Mar 09, 2021 Clinical Pharmacology

Comparison of aspirin monotherapy vs dual antiplatelet therapy following coronary artery bypass grafting

The American Journal of Cardiology | Mar 06, 2021 Clinical Pharmacology

Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification

Catheterization and Cardiovascular Interventions | Mar 06, 2021 Clinical Pharmacology

Medical therapy vs revascularization in patients with stable ischemic heart disease and advanced chronic kidney disease

Current Cardiology Reports | Mar 06, 2021 Clinical Pharmacology

Association of left anterior descending coronary artery radiation dose with adverse cardiac events in patients with NSCLC

JAMA | Feb 24, 2021 Clinical Pharmacology

Efficacy and safety of dapagliflozin according to etiology in heart failure with reduced ejection fraction: Insights from the DAPA‐HF trial

European Journal of Heart Failure | Feb 20, 2021 Clinical Pharmacology

Angiotensin‐converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin‐converting enzyme 2 in patients with cardiovascular disease

European Journal of Heart Failure | Feb 14, 2021 Clinical Pharmacology

Empagliflozin effects on pulmonary artery pressure in patients with heart failure: Results from EMpagliflozin Evaluation By MeasuRing ImpAct on HemodynamiCs in PatiEnts with Heart Failure (EMBRACE-HF) Trial

Circulation | Feb 12, 2021 Clinical Pharmacology

« Prev 1 … 28 29 30 31 32 … 163 Next »

Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction

Fenofibrate delays the need for dialysis and reduces cardiovascular risk among patients with advanced CKD

Sodium bicarbonate administration during in-hospital pediatric cardiac arrest: A systematic review and meta-analysis

Comparison of aspirin monotherapy vs dual antiplatelet therapy following coronary artery bypass grafting

Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification

Medical therapy vs revascularization in patients with stable ischemic heart disease and advanced chronic kidney disease

Association of left anterior descending coronary artery radiation dose with adverse cardiac events in patients with NSCLC

Efficacy and safety of dapagliflozin according to etiology in heart failure with reduced ejection fraction: Insights from the DAPA‐HF trial

Angiotensin‐converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin‐converting enzyme 2 in patients with cardiovascular disease

Empagliflozin effects on pulmonary artery pressure in patients with heart failure: Results from EMpagliflozin Evaluation By MeasuRing ImpAct on HemodynamiCs in PatiEnts with Heart Failure (EMBRACE-HF) Trial

Article on Hypertension in CKD Patients: Management Updates

Artice: Adult Vaccination Updates Every Family Doctor Should Know

MD Clip on Diabetes and Urinary ACR with Dr Saraogi

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

New research aims to transform treatments of aggressive blood cancer

Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction

Fenofibrate delays the need for dialysis and reduces cardiovascular risk among patients with advanced CKD

Sodium bicarbonate administration during in-hospital pediatric cardiac arrest: A systematic review and meta-analysis

Comparison of aspirin monotherapy vs dual antiplatelet therapy following coronary artery bypass grafting

Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification

Medical therapy vs revascularization in patients with stable ischemic heart disease and advanced chronic kidney disease

Association of left anterior descending coronary artery radiation dose with adverse cardiac events in patients with NSCLC

Efficacy and safety of dapagliflozin according to etiology in heart failure with reduced ejection fraction: Insights from the DAPA‐HF trial

Angiotensin‐converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin‐converting enzyme 2 in patients with cardiovascular disease

Empagliflozin effects on pulmonary artery pressure in patients with heart failure: Results from EMpagliflozin Evaluation By MeasuRing ImpAct on HemodynamiCs in PatiEnts with Heart Failure (EMBRACE-HF) Trial

Article on Hypertension in CKD Patients: Management Updates

Artice: Adult Vaccination Updates Every Family Doctor Should Know

MD Clip on Diabetes and Urinary ACR with Dr Saraogi

Article: TSH Abnormalities and Treatment Algorithms in Primary Care

New research aims to transform treatments of aggressive blood cancer

Select Specialty

Select Topic